Lv1
30 积分 2024-07-18 加入
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
1个月前
已完结
Breast Cancer Subtypes Predispose the Site of Distant Metastases
5个月前
已关闭
Vascular Normalization Augments the Anti-tumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors
5个月前
已完结
Vascular Normalization Augments the Anti-tumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors
8个月前
已完结
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
9个月前
已完结
The next generation of immunotherapies for lung cancers
9个月前
已完结
皖公网安备34019202002308
